These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1173 related items for PubMed ID: 28460563

  • 1. A review of sleep disorders and melatonin.
    Xie Z, Chen F, Li WA, Geng X, Li C, Meng X, Feng Y, Liu W, Yu F.
    Neurol Res; 2017 Jun; 39(6):559-565. PubMed ID: 28460563
    [Abstract] [Full Text] [Related]

  • 2. [Melatonin receptor agonist].
    Uchiyama M.
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [Abstract] [Full Text] [Related]

  • 3. The use of melatonin for the treatment of insomnia.
    Zisapel N.
    Biol Signals Recept; 1999 Jun; 8(1-2):84-9. PubMed ID: 10085468
    [Abstract] [Full Text] [Related]

  • 4. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].
    Quera-Salva MA, Claustrat B.
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [Abstract] [Full Text] [Related]

  • 5. Role of melatonin in the regulation of human circadian rhythms and sleep.
    Cajochen C, Kräuchi K, Wirz-Justice A.
    J Neuroendocrinol; 2003 Apr; 15(4):432-7. PubMed ID: 12622846
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Melatonin: therapeutic use in sleep disorders.
    Chase JE, Gidal BE.
    Ann Pharmacother; 1997 Oct; 31(10):1218-26. PubMed ID: 9337448
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
    Lancet; 2009 Feb 07; 373(9662):482-91. PubMed ID: 19054552
    [Abstract] [Full Text] [Related]

  • 12. Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders.
    Rodenbeck A, Huether G, Rüther E, Hajak G.
    Adv Exp Med Biol; 1999 Feb 07; 467():89-93. PubMed ID: 10721043
    [Abstract] [Full Text] [Related]

  • 13. [Disturbances in melatonin secretion and the efficacy of replacement therapy in sleep disorders].
    Zybina NN, Tikhomirova OV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018 Feb 07; 118(4. Vyp. 2):92-98. PubMed ID: 30059057
    [Abstract] [Full Text] [Related]

  • 14. Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms.
    Folkard S, Arendt J, Aldhous M, Kennett H.
    Neurosci Lett; 1990 May 31; 113(2):193-8. PubMed ID: 2377316
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Sun SY, Chen GH.
    Curr Neuropharmacol; 2022 May 31; 20(6):1022-1034. PubMed ID: 34493186
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of melatonin in the treatment of phase shift and sleep disorders.
    Skene DJ, Lockley SW, Arendt J.
    Adv Exp Med Biol; 1999 May 31; 467():79-84. PubMed ID: 10721041
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Melatonin: Physiological effects in humans.
    Claustrat B, Leston J.
    Neurochirurgie; 2015 May 31; 61(2-3):77-84. PubMed ID: 25908646
    [Abstract] [Full Text] [Related]

  • 20. Sleep-wake profiles and circadian rhythms of core temperature and melatonin in young people with affective disorders.
    Carpenter JS, Robillard R, Hermens DF, Naismith SL, Gordon C, Scott EM, Hickie IB.
    J Psychiatr Res; 2017 Nov 31; 94():131-138. PubMed ID: 28711776
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 59.